Saturday, November 17, 2018

The EMA is in the process of restricting use of FQs!

"EMA’s (European Medicines Agency) human medicines committee (CHMP) has endorsed the recommendations of EMA’s safety committee (PRAC) and concluded that the marketing authorisation of medicines containing cinoxacin, flumequine, nalidixic acid, and pipemidic acid should be suspended."

For the complete report from the EMA dated, November 16th, 2018, please see the following link;

We are being heard so please keep speaking up about the dangers of these antibiotics. You never know who you will save from the debilitating and disastrous damage these medicines do.

Yours In Health,


No comments:

Post a Comment